AUPH FY 2014 Earnings — Aurinia Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

AUPHAurinia Pharmaceuticals Inc.

$2B

FY 2014 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$278,000-70.7% YoY

Gross Profit

$241,00086.7% margin

Operating Income

-$17M-6216.5% margin

Net Income

-$17M-5988.1% margin

EPS (Diluted)

$-0.57

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$52M

Total Liabilities

$7M

Stockholders' Equity

$45M

Cash & Equivalents

$23M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$278,000	$948,561	-70.7%
Gross Profit	$241,000	$947,621	-74.6%
Operating Income	-$17M	-$6M	-213.9%
Net Income	-$17M	-$3M	-553.8%